Kyverna Therapeutics Inc (KYTX)

May 04, 2025

Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) should contact Levi & Korsinsky about pending Class ActionKYTX - ACCESS Newswire

May 04, 2025

May 02, 2025

Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

May 02, 2025

May 02, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Shareholders - ACCESS Newswire

May 02, 2025

May 02, 2025

Shareholders of Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your RightsKYTX - ACCESS Newswire

May 02, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

May 01, 2025

Brokerages Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) PT at $18.33 - MarketBeat

May 01, 2025

Apr 26, 2025

Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your RightsKYTX - ACCESS Newswire

Apr 26, 2025

Apr 24, 2025

KYTX Stock Price and Chart — NASDAQ:KYTX - TradingView

Apr 24, 2025

Apr 23, 2025

Gilead Sciences Inc. Purchases New Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Apr 23, 2025

Apr 20, 2025

JPMorgan Chase & Co. Sells 220,915 Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Apr 20, 2025

Apr 18, 2025

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Sold by Franklin Resources Inc. - MarketBeat

Apr 18, 2025

Apr 17, 2025

Notice to Long-Term Shareholders of Kyverna Therapeutics, - GlobeNewswire

Apr 17, 2025

Apr 17, 2025

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode - Bluefield Daily Telegraph

Apr 17, 2025

Apr 17, 2025

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR)Grabar Law Office Is Investigating Claims - TradingView

Apr 17, 2025

Apr 16, 2025

Investigation announced for Long-Term Investors in shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) - openPR.com

Apr 16, 2025

Apr 15, 2025

Robbins LLP Reminds Kyverna Therapeutics, Inc. Investors of the Pending Securities Fraud Class Action Against KYTX - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Kyverna Therapeutics Files For Offering Of Up To $50 Mln Common Stock From Time To TimeSEC Filing - marketscreener.com

Apr 15, 2025

Apr 11, 2025

HC Wainwright Has Negative Outlook for KYTX Q1 Earnings - MarketBeat

Apr 11, 2025

Apr 08, 2025

HC Wainwright Cuts Kyverna Therapeutics (NASDAQ:KYTX) Price Target to $4.00 - MarketBeat

Apr 08, 2025